Stephens Consulting’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-25
Closed -$337 1994
2025
Q1
$337 Buy
+25
New +$337 ﹤0.01% 1398